29.06.2010
NanoPowers raises CHF 5 million
NanoPowers SA, a medical device company that leverages its artificial muscle technology to restore or improve muscle function, closed a CHF 5 million series A financing. The financing round was led by Novartis Venture Funds, other partners were Initiative Capital Romandie and Gran Plasa SA. Novartis Venture Funds has been engaged from an early stage on as seed investors.
NanoPowers was founded in 2004 and profited from CTI Start-up Coaching. The company received the CTI Start-up Label in September 2009.
For more information go to: www.nanopowers.ch